Company update: DSM Q1 2011

Life Sciences company DSM reported its Q1 results this week. EBITDA from continuing operations was up 14 percent to € 325 million (US$481.455 million). 2011 is expected to be a strong year for DSM towards achieving the 2013 targets. Life Sciences results were driven by ongoing good performance in Nutrition and Materials Sciences posted solid results reflecting volume gains and pricing strength.

Feike Sijbesma, CEO/Chairman of the DSM Managing Board, said: "Our robust performance in Q1 2011 represents further progress towards our 2013 targets as we continue to successfully execute our strategy. In the quarter we successfully completed our acquisition of Martek, welcoming its employees to DSM.

The integration of Martek started immediately and the contribution to our profit is in line with expectations. Our business outlook for the rest of the year is positive and we expect 2011 to be a strong year for DSM." Read more ...

This blog is written by Martin Little The Global Miller, published and supported by the GFMT Magazine and International Milling Directory from Perendale Publishers